Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4393-4399

  Gray, Mary C ^a   Ross, William ^a   Kim, Keejun ^a   Hewlett, Erik L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BACTERIAL TOXIN; CYCLIC AMP; POTASSIUM ION; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ERYTHROCYTE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SHEEP; T LYMPHOCYTE; TARGET CELL;

EID: 0032813035     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4393-4399.1999     Document Type: Article

References (44)

1. Barry, E. M., A. A. Weiss, I. E. Ehrmann, M. C. Gray, E. L. Hewlett, and M. S. Goodwin. 1991. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J. Bacteriol. 173: 720-726.
2. Bauer, M. E., and R. A. Welch. 1996. Association of RTX toxins with erythrocytes. Infect. Immun. 64:4665-4672.
3. Bellalou, J., H. Sakamoto, D. Ladant, C. Geoffroy, and A. Ullmann. 1990. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect. Immun. 58:3242-3247.
4. Berkowitz, S. A., A. R. Goldhammer, E. L. Hewlett, and J. Wolff. 1980. Activation of prokaryotic adenylate cyclase by calmodulin. Ann. N. Y. Acad. Sci. 1:356-360.
5. Boehm, D. F., R. A. Welch, and I. S. Snjder. 1990. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes. Infect. Immun. 58:1951-1958.
6. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58:1959-1964.
7. Brooker, G., J. F. Harper, W. L. Terasaki, and R. D. Moylan. 1979. Radio-immunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10:1-33.
8. Confer, D. L., A. S. Slungaard, E. Graf, S. S. Panter, and J. W. Eaton. 1984. Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17: 183-187.
9. Coote, J. G. 1992. Structural and functional relationships among the RTX toxin determinants of gram-negative bacteria. FEMS Microbiol. Rev. 88: 137-162.
10. Ehrmann, I., A. Wells, M. S. Goodwin, M. C. Gray, E. Barry, and E. L. Hewlett. 1992. Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis. FEBS Lett. 304:51-56.
11. Ehrmann, I. E., M. C. Gray, V. M. Gordon, L. S. Gray, and E. L. Hewlett. 1991. Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett. 278:79-83.
12. Endoh, M., T. Takezawa, and Y. Nakase. 1980. Adenylate cyclase activity of Bordetella organisms. I. Its production in liquid medium. Microbiol. Immunol. 24:95-104.
13. Gentile, F., A. Raptis, L. G. Knipling, and J. Wolf. 1988. Bordetella pertussis adenylate cyclase. Penetration into host cells. Eur. J. Biochem. 175:447-453.
14. Glaser, P., D. Ladant, O. Sezer, F. Pichot, A. Ullmann, and A. Danchin. 1988. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol. Microbiol. 2:19-30.
15. Gordon, V. M., W. W. Young, Jr., S. M. Lechler, M. C. Gray, S. H. Leppla, and E. L. Hewlett. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 264:14792-14796.
16. Gray, M., G. Szabo, A. S. Otero, L. Gray, and E. Hewlett. 1998. Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J. Biol. Chem. 273:18260-18267.
17. Guiso, N., M. Rocancourt, S. Szatanih, and J. Alonso. 1989. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Microb. Pathog. 7:373-380.
18. Hackett, M., L. Guo, J. Shabanowitz, D. F. Hunt, and E. L. Hewlett. 1994. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266:433-435.
19. Hanski, E., and Z. Farfel. 1985. Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J. Biol. Chem. 290:5526-5532.
20. Hewlett, E. L., and M. C. Gray. Bacterial protein toxins. In K. Aktories and I. Just (ed.), Handbook of experimental pharmacology, in press. Springer-Verlag, Heidelberg, Germany.
21. Hewlett, E. L., and V. M. Gordon. 1988. Adenylate cyclase toxin of Bordetella pertussis. p. 193-209. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons, New York, N.Y.
22. Hewlett, E. L., V. M. Gordon, J. D. McCaffery, W. M. Sutherland, and M. C. Gray. 1989. Adenylate cyclase toxin from Bordetella pertussis. Identification and purification of the holotoxin molecule. J. Biol. Chem. 264:19379-19384.
23. Hewlett, E. L., L. Gray, M. Allietta, I. Ehrmann, V. M. Gordon, and M. C. Gray. 1991. Adenylate cyclase toxin from Bordetella pertussis. Conformational change associated with toxin activity. J. Biol. Chem. 266:17503-17508.
24. Hewlett, E. L., M. C. Gray, I. E. Ehrmann, N. J. Maloney, A. S. Otero, L. Gray, M. Allietta, G. Szabo, A. A. Weiss, and E. M. Barry. 1993. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene cyaC. J. Biol. Chem. 268:7842-7848.
25. Iwaki, M., A. Ullmann, and P. Sebo. 1995. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol. Microbiol. 17:1015-1024.
26. Iwamori, M., J. Shimomura, and Y. Nagai. 1985. Specific binding of cholera toxin to rat erythrocytes revealed by analysis with a fluorescence-activated cell sorter. J. Biochem. 97:729-735.
27. Kurpisz, M., S. K. Pupta, D. L. Fulgham, and N. J. Alexander. 1988. Production of large amounts of mouse polyclonal antisera. J. Immunol. Methods 115:195-198.
28. Lee, S. J., M. C. Gray, P. Sebo, and E. L. Hewlett. 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 67:2090-2095.
29. Manahan, W., and A. Paraf. 1993. Mice ascites as a source of polyclonal and monoclonal antibodies. J. Immunol. Methods 161:187-192.
30. Moayeri, M., and R. A. Welch. 1997. Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin. Infect. Immun. 65:2233-2239.
31. Ostolaza, H., and F. M. Goni. 1995. Interaction of the bacterial protein toxin alpha-haemolysin with model membranes: protein binding does not always lead to lytic activity. FEBS Lett. 371:303-306.
32. Ostolaza, H., A. Soloaga, and F. M. Goni. 1995. The binding of divalent cations to Escherichia coli alpha-haemolysin. Eur. J. Biochem. 228:39-44.
33. Pearson, R. D., P. Symes, M. Conboy, A. A. Weiss, and E. L. Hewlett. 1987. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J. Immunol. 139:2749-2754.
34. Rogel, A., and E. Hanski. 1992. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J. Biol. Chem. 267:22599-22605.
35. Rogel, A., R. Meller, and E. Hanski. 1991. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis. J. Biol. Chem. 266:3154-3161.
36. Rogel, A., J. E. Schultz, R. M. Brownlie, J. G. Coote, R. Parton, and E. Hanski. 1989. Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme. EMBO J. 8:2755-2760.
37. Rose, T., P. Sebo, J. Bellalou, and D. Ladant. 1995. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J. Biol. Chem. 270:26370-26376.
38. Sakamoto, H., J. Bellalou, P. Sebo, and D. Ladant. 1992. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities. J. Biol. Chem. 267:13598-13602.
39. Sebo, P., P. Glaser, H. Sakamoto, and A. Ullmann. 1991. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Gene 104:19-24.
40. Selfe, S., D. D. Hunter, R. L. Shattuck, N. M. Nathanson, and D. R. Storm. 1987. Alteration of intracellular cAMP levels and beating rates of cultured chick cardiac cells by Bordetella pertussis adenylate cyclase. Mol. Pharmacol. 31:529-534.
41. Shulman, M., C. D. Wilde, and G. Kohler. 1978. A better cell line for making hybridomas secreting specific antibodies. Nature 276:269-270.
42. Soloaga, A., H. Ostolaza, F. M. Goni, and F. de la Cruz. 1996. Purification of Escherichia coli pro-haemolysin, and a comparison with the properties of mature a-haemolysin. Eur. J. Biochem. 238:418-422.
43. Szabo, G., M. C. Gray, and E. L. Hewlett 1994. Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J. Biol. Chem. 269:22496-22499.
44. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33-41.